Application of leucocythemia related to gene ASH2L in leukemia molecule classification diagnosis
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- THE INST OF BASIC MEDICAL SCI OF CHINESE ACAD OF MEDICAL SCI
- Publication Date
- 2006-11-29
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the fields of gene recombination, antibody preparation and clinical diagnosis. Specifically, the present invention relates to a recombinant genetic engineering and protein purification process of the N-terminal part of the leukemia-related gene ASH2L, to the recombinant genetic engineering and protein purification process of the full-length ASH2L interacting protein DPY-30-like, and to the use of The preparation of highly specific antibodies from these two purified proteins involves the specific downregulation of ASH2L during the differentiation process of K562 cells stimulated by PMA, the recombinant plasmids containing part of the ASH2L gene and the recombinant strains expressing the protein and their use in the molecular typing diagnosis of leukemia Applications. Background technique
[0002] Accurate classification of leukemia is an important prerequisite for the treatment of leukemia. At present, the diagnosis and typing...